By-health Co., Ltd. (300146.SZ)
CNY 10.99
(0.09%)
CNY 10.99
(0.09%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 2.48 Billion CNY | -3.1% |
| 2022 | 1.95 Billion CNY | -10.16% |
| 2021 | 2.41 Billion CNY | 37.58% |
| 2020 | 2 Billion CNY | 9.81% |
| 2019 | -120.39 Million CNY | 10.04% |
| 2018 | 1.3 Billion CNY | 34.75% |
| 2017 | 995.85 Million CNY | 34.93% |
| 2016 | 764.4 Million CNY | 6.63% |
| 2015 | 747.88 Million CNY | 19.0% |
| 2014 | 590.63 Million CNY | 15.57% |
| 2013 | 521.79 Million CNY | 47.2% |
| 2012 | 355.97 Million CNY | 61.24% |
| 2011 | 227.47 Million CNY | 102.11% |
| 2010 | 112.93 Million CNY | 76.26% |
| 2009 | 63.96 Million CNY | 80.56% |
| 2008 | 35.47 Million CNY | 88.21% |
| 2007 | 18.92 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -39.32 Million CNY | -114.81% |
| 2024 Q1 | 911.46 Million CNY | 953.51% |
| 2024 Q2 | 187.27 Million CNY | -72.39% |
| 2023 Q3 | 433 Million CNY | -30.59% |
| 2023 Q1 | 1.35 Billion CNY | 7144.06% |
| 2023 Q2 | 623.82 Million CNY | -54.1% |
| 2023 FY | - CNY | -3.1% |
| 2023 Q4 | -209.07 Million CNY | -148.28% |
| 2022 Q3 | 530.98 Million CNY | 8.06% |
| 2022 Q2 | 491.39 Million CNY | -46.5% |
| 2022 Q1 | 918.56 Million CNY | 12093.14% |
| 2022 FY | - CNY | -10.16% |
| 2022 Q4 | -19.29 Million CNY | -103.63% |
| 2021 Q2 | 674.01 Million CNY | -37.01% |
| 2021 Q1 | 1.07 Billion CNY | 412.92% |
| 2021 FY | - CNY | 37.58% |
| 2021 Q4 | 7.53 Million CNY | -98.18% |
| 2021 Q3 | 413.04 Million CNY | -38.72% |
| 2020 Q1 | 710.02 Million CNY | 1267.01% |
| 2020 Q4 | -341.96 Million CNY | -151.33% |
| 2020 Q3 | 666.17 Million CNY | 29.73% |
| 2020 FY | - CNY | 9.81% |
| 2020 Q2 | 513.51 Million CNY | -27.68% |
| 2019 Q1 | 650.59 Million CNY | 1475.34% |
| 2019 Q3 | 365.32 Million CNY | -8.94% |
| 2019 FY | - CNY | 10.04% |
| 2019 Q4 | -60.84 Million CNY | -116.65% |
| 2019 Q2 | 401.19 Million CNY | -38.33% |
| 2018 FY | - CNY | 34.75% |
| 2018 Q2 | 434.86 Million CNY | -13.6% |
| 2018 Q1 | 503.31 Million CNY | 256.5% |
| 2018 Q3 | 433.99 Million CNY | -0.2% |
| 2018 Q4 | -47.3 Million CNY | -110.9% |
| 2017 Q3 | 267.35 Million CNY | -35.42% |
| 2017 Q4 | 141.18 Million CNY | -47.19% |
| 2017 FY | - CNY | 34.93% |
| 2017 Q1 | 318.69 Million CNY | 185.72% |
| 2017 Q2 | 413.96 Million CNY | 29.9% |
| 2016 Q3 | 225.03 Million CNY | 5.25% |
| 2016 Q4 | 111.54 Million CNY | -50.43% |
| 2016 FY | - CNY | 6.63% |
| 2016 Q1 | 237.63 Million CNY | 304.25% |
| 2016 Q2 | 213.8 Million CNY | -10.03% |
| 2015 Q3 | 175.73 Million CNY | -29.25% |
| 2015 FY | - CNY | 19.0% |
| 2015 Q4 | 58.78 Million CNY | -66.55% |
| 2015 Q2 | 248.38 Million CNY | 11.65% |
| 2015 Q1 | 222.47 Million CNY | 309.74% |
| 2014 Q4 | 54.29 Million CNY | -63.27% |
| 2014 Q2 | 192.76 Million CNY | -5.4% |
| 2014 Q3 | 147.83 Million CNY | -23.31% |
| 2014 FY | - CNY | 15.57% |
| 2014 Q1 | 203.77 Million CNY | 114.23% |
| 2013 Q3 | 151.06 Million CNY | 10.09% |
| 2013 FY | - CNY | 47.2% |
| 2013 Q1 | 138.48 Million CNY | 68.23% |
| 2013 Q2 | 137.21 Million CNY | -0.92% |
| 2013 Q4 | 95.12 Million CNY | -37.03% |
| 2012 Q4 | 82.32 Million CNY | 25.07% |
| 2012 FY | - CNY | 61.24% |
| 2012 Q3 | 65.82 Million CNY | -15.52% |
| 2012 Q2 | 77.91 Million CNY | -35.97% |
| 2012 Q1 | 121.67 Million CNY | 79.51% |
| 2011 Q3 | 63.78 Million CNY | 0.51% |
| 2011 Q4 | 67.78 Million CNY | 6.27% |
| 2011 Q1 | 43.59 Million CNY | 105.45% |
| 2011 Q2 | 63.46 Million CNY | 45.56% |
| 2011 FY | - CNY | 102.11% |
| 2010 Q4 | 21.22 Million CNY | -2.08% |
| 2010 Q3 | 21.67 Million CNY | -17.91% |
| 2010 FY | - CNY | 76.26% |
| 2010 Q2 | 26.4 Million CNY | -31.77% |
| 2010 Q1 | 38.69 Million CNY | 340.9% |
| 2009 FY | - CNY | 80.56% |
| 2009 Q3 | 16.32 Million CNY | 0.0% |
| 2009 Q4 | 8.77 Million CNY | -46.25% |
| 2008 FY | - CNY | 88.21% |
| 2007 FY | - CNY | 0.0% |